Precision dosing in children; no small matter

L M Hanff¹

Affiliations

Editorial

L M Hanff. Eur J Cancer. 2022 Mar.

. 2022 Mar:164:155-156.

doi: 10.1016/j.ejca.2021.11.007. Epub 2021 Dec 4.

L M Hanff¹

¹ Princess Maxima Centre for Pediatric Oncology, the Netherlands. Electronic address: L.M.Hanff@prinsesmaximacentrum.nl.

No abstract available

Conflict of interest statement

Conflict of interest statement The authors declare no conflict of interest.

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients.
Barnett S, Hellmann F, Parke E, Makin G, Tweddle DA, Osborne C, Hempel G, Veal GJ. Barnett S, et al. Eur J Cancer. 2022 Mar;164:127-136. doi: 10.1016/j.ejca.2021.09.014. Epub 2021 Oct 14. Eur J Cancer. 2022. PMID: 34657763 Free PMC article.
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.
Nijstad AL, Barnett S, Lalmohamed A, Bérénos IM, Parke E, Carruthers V, Tweddle DA, Kong J, Zwaan CM, Huitema ADR, Veal GJ. Nijstad AL, et al. Eur J Cancer. 2022 Mar;164:137-154. doi: 10.1016/j.ejca.2021.11.001. Epub 2021 Dec 2. Eur J Cancer. 2022. PMID: 34865945 Free PMC article.